Joseph J. Ferra, Jr
2018
In 2018, Joseph J. Ferra, Jr earned a total compensation of $2.4M as Chief Financial Officer at Syros Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $1,861,320 |
| Salary | $323,077 |
| Other | $50,225 |
| Total | $2,394,622 |
Ferra received $1.9M in option awards, accounting for 78% of the total pay in 2018.
Ferra also received $160K in non-equity incentive plan, $323.1K in salary and $50.2K in other compensation.
Rankings
In 2018, Joseph J. Ferra, Jr's compensation ranked 4,860th out of 14,244 executives tracked by ExecPay. In other words, Ferra earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,860 out of 14,244 | 66th |
Division Manufacturing | 1,826 out of 5,765 | 68th |
Major group Chemicals And Allied Products | 665 out of 2,128 | 69th |
Industry group Drugs | 559 out of 1,817 | 69th |
Industry Pharmaceutical Preparations | 432 out of 1,391 | 69th |
Source: SEC filing on April 25, 2019.
Ferra's colleagues
We found three more compensation records of executives who worked with Joseph J. Ferra, Jr at Syros Pharmaceuticals in 2018.